Correlation Between Adaptimmune Therapeutics and VectivBio Holding
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and VectivBio Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and VectivBio Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and VectivBio Holding AG, you can compare the effects of market volatilities on Adaptimmune Therapeutics and VectivBio Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of VectivBio Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and VectivBio Holding.
Diversification Opportunities for Adaptimmune Therapeutics and VectivBio Holding
-0.88 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Adaptimmune and VectivBio is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and VectivBio Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VectivBio Holding and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with VectivBio Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VectivBio Holding has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and VectivBio Holding go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and VectivBio Holding
If you would invest 1,685 in VectivBio Holding AG on August 26, 2024 and sell it today you would earn a total of 0.00 from holding VectivBio Holding AG or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 1.54% |
Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. VectivBio Holding AG
Performance |
Timeline |
Adaptimmune Therapeutics |
VectivBio Holding |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Adaptimmune Therapeutics and VectivBio Holding Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Adaptimmune Therapeutics and VectivBio Holding
The main advantage of trading using opposite Adaptimmune Therapeutics and VectivBio Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, VectivBio Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VectivBio Holding will offset losses from the drop in VectivBio Holding's long position.The idea behind Adaptimmune Therapeutics Plc and VectivBio Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
VectivBio Holding vs. Cns Pharmaceuticals | VectivBio Holding vs. ZyVersa Therapeutics | VectivBio Holding vs. Immix Biopharma | VectivBio Holding vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |